This study clarifies a critical variable in gerotherapeutics: the route and duration of administration do not simply alter the magnitude of a drugs efficacy
CXCL1 was significantly upregulated in mice subjected to a high-fat diet (HFD) and ethanol exposure, while both CXCL1 knockout and anti-CXCL1 treatment protected these mice from neutrophil-mediated liver injury [66]
Expert Opinion on Biological Therapy, 12(1), 37-51
The available evidence is preclinical and comes from cell and animal research
Ideal candidates include adults seeking the most comprehensive anti-aging support available, individuals wanting to address cosmetic aging, cellular health, and metabolic function simultaneously, patients committed to aggressive healthspan optimization, those interested in the most complete multi-pathway anti-aging protocol, and individuals who want maximum synergistic benefits from peptide therapy